Trial Profile
Phase I-II Study of Preoperative Oxaliplatin-FU and Radiotherapy for Patients With Rectal Cancer.
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 16 Jul 2009
Price :
$35
*
At a glance
- Drugs Fluorouracil (Primary) ; Oxaliplatin (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Sanofi
- 08 Sep 2008 Actual patient number (46) added as reported by ClinicalTrials.gov.
- 08 Sep 2008 Planned end date added (1 Jun 2006) as reported by ClinicalTrials.gov.
- 22 Dec 2005 New trial record.